Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Laboratory), Therapeutic Area (Oncology, Infectious Disease), Molecule Type (Vaccine, CGT), End User (Pharma, Biopharma, Research Institute) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The contract research organization (CRO) services market is projected to reach USD 86.5 billion by 2026 from USD 53.2 billion in 2021, at a CAGR of 10.7% during the forecast period.
The increasing number of clinical trials and the rising prevalence of orphan and rare diseases are some of the factors that have supported long-term expansion for Contract Research Organization (CROs) Services Market.
Contract Research Organization (CROs) Services Market is segmented into type, therapeutic area, molecule type, end user and geography.
Type segment is segmented into early phase development services, clinical research services, laboratory services, consulting services, and data management.
Therapeutic area segment is segmented into Oncology, Infectious Diseases, Neurology, CVS, Metabolic Disorders/Endocrinology, Immunological Disorders, Respiratory Disorders, Psychiatry, Dermatology, Haematology, Ophthalmology, Gastrointestinal and Genitourinary & Women’s Health
Molecule type vaccines and cell and gene therapy diseases.
End user segment is segmented into pharmaceutical & biotechnology companies, medical device companies and academic institutes.
Geographically, the global Contract Research Organization (CROs) Services market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions.
Key players in global Contract Research Organization (CROs) Services market are IQVIA (US), LabCorp (US), Charles River Laboratories (US), WuXi AppTec (China), Syneos Health (US), Parexel International (US), PPD (US), ICON Plc (US), Medpace Holdings (US), SGS (Switzerland), PSI CRO AG (US), Axcent Advanced Analytics (US), BIO Agile Therapeutics (US), Firma Clinical Research (US), Acculab Life Sciences (US), Azelix (US), CTserv (US), Pepgra (UK), and Dove Quality Solutions (US), Novotech Health Holding (Australia), Geneticist Inc. (US), Linical Americas (US), Frontage Holding Corporation (US), and Celerion (US).
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 53.2 billion |
Growth Rate |
CAGR of 10.7% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
type, therapeutic area, molecule type, end user and geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
IQVIA (US), LabCorp (US), Charles River Laboratories (US), WuXi AppTec (China), Syneos Health (US), Parexel International (US), PPD (US), ICON Plc (US), Medpace Holdings (US), SGS (Switzerland), PSI CRO AG (US), Axcent Advanced Analytics (US), BIO Agile Therapeutics (US), Firma Clinical Research (US), Acculab Life Sciences (US), Azelix (US), CTserv (US), Pepgra (UK), and Dove Quality Solutions (US), Novotech Health Holding (Australia), Geneticist Inc. (US), Linical Americas (US), Frontage Holding Corporation (US), and Celerion (US). |
Available Customization |
In addition to the market data for Contract Research Organization (CROs) Services Market, Delvens. offers client-centric report and customized according to the company’s specific demand and requirement. |